The Valley Desk

NCT00616655 · Interventional trial

Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects

Overall registry status Completed

Phase 2

Conditions Generalized Anxiety Disorder

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov